Medicine Description combivent 0.1mg
Combivent 0.1mg Inhalation is a medication that combines ipratropium bromide, an anticholinergic agent, with salbutamol, a beta-2 adrenergic agonist, to provide dual-action bronchodilation. Ipratropium bromide works by selectively antagonizing muscarinic receptors in the bronchial smooth muscle, thereby inhibiting the action of acetylcholine. This results in relaxation of bronchial muscles, reducing bronchoconstriction. Salbutamol complements this action by stimulating beta-2 adrenergic receptors, which further enhances bronchodilation through increased intracellular cyclic AMP levels. The combination effectively opens the airways, improving airflow and alleviating symptoms in individuals with obstructive airway diseases.
Indications and Uses of Combivent 0.1mg Inhalation
- Management of chronic obstructive pulmonary disease (COPD)
- Relief of bronchospasm associated with asthma
- Prevention of exercise-induced bronchoconstriction
- Adjunctive therapy in patients experiencing acute exacerbations of COPD or asthma
Side Effects of Combivent 0.1mg Inhalation
- Dry mouth
- Headache
- Nervousness
- Tremors
- Palpitations
- Cough
- Throat irritation
- Increased heart rate
Storage and Handling
Store Combivent 0.1mg Inhalation at room temperature, away from direct sunlight and moisture. Keep the inhaler cap tightly closed when not in use and out of reach of children.
Patient Advice and Precautions
Patients should be instructed to shake the inhaler well before use and to exhale fully before inhaling the medication. It is important to avoid contact with the eyes, as it may cause irritation. Regular monitoring of lung function is advised, and any sudden worsening of symptoms should prompt immediate medical consultation.